UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(MARK ONE)

☒

Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
for the quarterly period ended ~~September~~June 30, ~~2017.~~2023.

☐

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
for the transition period from ___________to ________.

Commission File No.0-16469

INTER PARFUMS, INC.

(Exact name of registrant as specified in its charter)

Delaware		13-3275609
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

551 Fifth Avenue, New York, New York10176

(Address of Principal Executive Offices) (Zip Code)

(212)983-2640

(Registrants telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $.001 par value per share		IPAR		The Nasdaq Stock Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes☒ No ☐

Indicate by check mark whether the registrant has submitted electronically ~~and posted on its corporate Web site, if any,~~ every Interactive Data File required to be submitted ~~and posted~~ pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit ~~and post~~ such files).

Yes☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company or an emerging growth company. See ~~definition~~definitions of “large accelerated filer,” “accelerated ~~filer”~~filer,” “smaller reporting company,” and ~~“smaller reporting~~“emerging growth company” in Rule 12b-2 of the Exchange Act).

Large accelerated ~~Filer ☐~~filer ☒	Accelerated filer ☒☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company)	Smaller reporting company ☐
	Emerging Growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐No☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

At ~~November 7, 2017,~~August 8, 2023, there were ~~31,186,748~~31,975,670 shares of common stock, par value $.001 per share, outstanding.

INTER PARFUMS, INC. AND SUBSIDIARIES

INDEX

			Page Number

Part I.	Financial Information		1

	Item 1.	Financial Statements

		Consolidated Balance Sheets as of ~~September~~June 30, ~~2017~~2023 and December 31, ~~2016~~2022	2

		Consolidated Statements of Income for the Three and ~~Nine~~Six Months Ended ~~September~~ June 30, ~~2017~~2023 and ~~September~~June 30, ~~2016~~2022	3

		Consolidated Statements of Comprehensive Income for the Three and ~~Nine~~Six Months Ended ~~September~~ June 30, ~~2017~~2023 and ~~September~~June 30, ~~2016~~2022	4

		Consolidated Statements of Changes in Equity for the ~~Nine~~Six Months Ended ~~September~~ June 30, ~~2017~~2023 and ~~September~~June 30, ~~2016~~2022	5

		Consolidated Statements of Cash Flows for the ~~Nine~~Six Months Ended ~~September~~ June 30, ~~2017~~2023 and ~~September~~June 30, ~~2016~~2022	6

		Notes to Consolidated Financial Statements	7

	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1516

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3026

	Item 4.	Controls and Procedures	3127

Part II.	Other Information		3127

	Item 2.	Unregistered Sales of Equity Securities and Use of ~~Proceeds~~Proceeds.	3127

	Item 6.	Exhibits	3228

Signatures			32

INTER PARFUMS, INC. AND SUBSIDIARIES

~~Part I. Financial Information~~

Part I.

Financial Information

Item 1.

~~FINANCIAL STATEMENTS~~Financial Statements

In our opinion, the accompanying unaudited consolidated financial statements contain all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows for the interim periods presented. We have condensed such financial statements in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Therefore, such financial statements do not include all disclosures required by accounting principles generally accepted in the United States of America. In preparing these consolidated financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued by filing with the SEC. These financial statements should be read in conjunction with our audited financial statements for the year ended December 31, ~~2016~~2022, included in our annual report filed on Form 10-K.

The results of operations for the ~~nine~~six months ended ~~September~~June 30, ~~2017~~2023, are not necessarily indicative of the results to be expected for the entire fiscal year.

Page 1

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands except share and per share data)

(Unaudited)


ASSETS	ASSETS
		September 30, 2017			December 31, 2016				June 30, 2023			December 31, 2022
Current assets:
Cash and cash equivalents		$	108,367		$	161,828			$	74,311		$	104,713
Short-term investments			122,402			94,202				112,449			150,833
Accounts receivable, net			159,434			104,819				236,554			197,584
Inventories			134,280			96,977				360,018			289,984
Receivables, other			1,341			7,433				14,730			28,803
Other current assets			8,885			6,240				24,993			15,650
Income tax receivable			548			626
Income taxes receivable										386			157
Total current assets			535,257			472,125				823,441			787,724
Equipment and leasehold improvements, net			10,321			10,076
Property, equipment and leasehold improvements, net										168,264			166,722
Right-of-use assets, net										28,005			27,964
Trademarks, licenses and other intangible assets, net			200,841			183,868				292,319			290,853
Deferred tax assets			11,071			8,090				14,333			11,159
Other assets			8,183			8,250				25,302			24,120
Total assets		$	765,673		$	682,409			$	1,351,664		$	1,308,542

LIABILITIES AND EQUITY	LIABILITIES AND EQUITY							LIABILITIES AND EQUITY
Current liabilities:
Loans payable - banks									$	4,958		$	—
Current portion of long-term debt		$	24,016		$	21,498				29,080			28,547
Current portion of lease liabilities										5,236			5,296
Accounts payable – trade			54,449			49,507				91,040			88,388
Accrued expenses			63,113			62,609				194,036			213,621
Income taxes payable			10,970			3,331				17,324			8,715
Dividends payable			5,301			5,293
Total current liabilities			157,849			142,238				341,674			344,567
Long-term debt, less current portion			41,554			53,064
Deferred tax liability			3,741			3,449

Long–term debt, less current portion										138,565			151,494
Lease liabilities, less current portion										24,491			24,335

Equity:
Inter Parfums, Inc. shareholders’ equity:
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued			—			—
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,182,458 and 31,138,318 shares at September 30, 2017 and December 31, 2016, respectively			31			31
Preferred stock, $.001 par; authorized 1,000,000 shares; none issued										—			—
Common stock, $.001 par; authorized 100,000,000 shares; outstanding 31,975,670 and 31,967,300 shares at June 30, 2023 and December 31, 2022, respectively										32			32
Additional paid-in capital			64,645			63,103				95,984			90,186
Retained earnings			424,545			402,714				669,688			620,095
Accumulated other comprehensive loss			(23,061	)		(57,982	)			(48,739	)		(56,056	)
Treasury stock, at cost, 9,864,805 common shares at September 30, 2017 and December 31, 2016, respectively			(37,475	)		(37,475	)
Treasury stock, at cost, 9,949,865 and 9,864,805 shares at June 30, 2023 and December 31, 2022, respectively										(48,764	)		(37,475	)
Total Inter Parfums, Inc. shareholders’ equity			428,685			370,391				668,201			616,782
Noncontrolling interest			133,844			113,267				178,733			171,364
Total equity			562,529			483,658				846,934			788,146
Total liabilities and equity		$	765,673		$	682,409			$	1,351,664		$	1,308,542

See notes to consolidated financial statements.

Page 2

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In thousands except per share data)

(Unaudited)


	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended June 30,						Six Months Ended June 30,
	2017			2016			2017			2016			2023			2022			2023			2022

Net sales	$	169,531		$	157,622		$	441,725		$	386,301		$	309,244		$	244,725		$	620,967		$	495,403

Cost of sales		66,059			62,790			164,240			145,723			120,840			90,943			229,606			182,963

Gross margin		103,472			94,832			277,485			240,578			188,404			153,782			391,361			312,440

Selling, general and administrative expenses		70,309			62,529			203,676			179,285			133,383			108,385			246,061			205,825

Income from operations		33,163			32,303			73,809			61,293			55,021			45,397			145,300			106,615

Other expenses (income):
Interest expense		495			515			1,494			2,181			2,276			1,023			4,633			1,907
Loss on foreign currency		335			334			1,308			388
Interest income		(615	)		(765	)		(2,788	)		(2,722	)
(Gain) loss on foreign currency														(746	)		(279	)		13			(2,518	)
Interest and investment (income) loss														(1,977	)		(464	)		(7,359	)		1,002
Other income														(7	)		(328	)		(48	)		(444	)

		215			84			14			(153	)
Nonoperating Income (Expense)														(454	)		(48	)		(2,761	)		(53	)

Income before income taxes		32,948			32,219			73,795			61,446			55,475			45,445			148,061			106,668

Income taxes		10,845			10,740			24,314			22,790			12,957			10,925			34,635			25,857

Net income		22,103			21,479			49,481			38,656			42,518			34,520			113,426			80,811

Less: Net income attributable to the noncontrolling interest		5,026			5,240			12,287			9,252			7,566			6,903			24,406			17,895

Net income attributable to Inter Parfums, Inc.	$	17,077		$	16,239		$	37,194		$	29,404		$	34,952		$	27,617		$	89,020		$	62,916

Earnings per share:

Net income attributable to Inter Parfums, Inc. common shareholders:
Basic	$	0.55		$	0.52		$	1.19		$	0.95		$	1.09		$	0.87		$	2.78		$	1.98
Diluted	$	0.55		$	0.52		$	1.19		$	0.94		$	1.09		$	0.86		$	2.77		$	1.97

Weighted average number of shares outstanding:
Basic		31,175			31,080			31,163			31,058			32,006			31,845			32,012			31,843
Diluted		31,307			31,171			31,281			31,138			32,162			31,952			32,161			31,981


Dividends declared per share	$	0.17		$	0.15		$	0.51		$	0.45		$	0.625		$	0.50		$	1.30		$	1.00

See notes to consolidated financial statements.

Page 3

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In ~~thousands except per share data)~~thousands)

(Unaudited)


	Three Months Ended September 30,					Nine Months Ended September 30,				Three Months Ended June 30,						Six Months Ended June 30,
	2017			2016		2017		2016		2023			2022			2023			2022
Comprehensive income:

Net income	$	22,103		$	21,479	$	49,481	$	38,656	$	42,518		$	34,520		$	113,426		$	80,811

Other comprehensive income:

Net derivative instrument gain (loss), net of tax		(591	)		—		30		—
Net derivative instrument loss, net of tax											(77	)		(1,749	)		(4,243	)		(1,488	)

Transfer from OCI into earnings		—			—		22		—		—			—			1,709			992

Translation adjustments, net of tax		15,143			2,391		48,715		10,504		(454	)		(33,630	)		13,035			(46,071	)

Comprehensive income		36,655			23,870		98,248		49,160
Comprehensive income (loss)											41,987			(859	)		123,927			34,244

Comprehensive income attributable to the noncontrolling interests:

Net income		5,026			5,240		12,287		9,252		7,566			6,903			24,406			17,895

Other comprehensive income:
Other comprehensive income (loss):

Net derivative instrument gain (loss), net of tax		(160	)		—		8		—

Transfer from OCI into earnings		—			—		5		—
Net derivative instrument loss, net of tax											(21	)		(483	)		(227	)		(411	)

Translation adjustments, net of tax		4,367			698		13,833		3,141		(211	)		(10,743	)		3,411			(14,162	)

Comprehensive income attributable to the noncontrolling interests		9,233			5,938		26,133		12,393
Comprehensive income (loss) attributable to the noncontrolling interests											7,334			(4,323	)		27,590			3,322

Comprehensive income attributable to Inter Parfums, Inc.	$	27,422		$	17,932	$	72,115	$	36,767	$	34,653		$	3,464		$	96,337		$	30,922

See notes to consolidated financial statements.

Page 4

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands)

~~(Unaudited)~~(Unaudited)


	Nine months ended September 30,						Six months ended June 30,
	2017			2016			2023			2022

Common stock, beginning and end of period	$	31		$	31		$	32		$	32
								-			-
								32			32
Additional paid-in capital, beginning of period		63,103			62,030			90,186			87,132
Shares issued upon exercise of stock options		839			1,235			5,191			810
Purchase of subsidiary shares from noncontrolling interests		—			(1,670	)
Share based compensation		703			630
Sale of subsidiary shares to noncontrolling interest		—			(154	)
Share-based compensation								624			679
Purchase of subsidiary shares								(17	)		(4,305	)
Additional paid-in capital, end of period		64,645			62,071			95,984			84,316

Retained earnings, beginning of period		402,714			388,434			620,095			560,663
Net income		37,194			29,404			89,020			62,916
Dividends		(15,899	)		(13,980	)		(40,020	)		(31,844	)
Share based compensation		536			—
Share-based compensation								593			1,632
Retained earnings, end of period		424,545			403,858			669,688			593,367

Accumulated other comprehensive loss, beginning of period		(57,982	)		(48,091	)		(56,056	)		(38,432	)
Foreign currency translation adjustment, net of tax		34,882			7,363			9,624			(31,909	)
Transfer from other comprehensive income into earnings		17			—			1,709			992
Net derivative instrument gain, net of tax		22			—
Net derivative instrument loss, net of tax								(4,016	)		(1,077	)
Accumulated other comprehensive loss, end of period		(23,061	)		(40,728	)		(48,739	)		(70,426	)

Treasury stock, beginning and end of period		(37,475	)		(36,817	)		(37,475	)		(37,475	)
Shares repurchased								(11,289	)		—
Treasury stock, end of period								(48,764	)		(37,475	)

Noncontrolling interest, beginning of period		113,267			110,800			171,364			166,412
Net income		12,287			9,252			24,406			17,895
Foreign currency translation adjustment, net of tax		13,833			3,141			3,411			(14,162	)
Transfer from other comprehensive income into earnings		5			—
Net derivative instrument gain, net of tax		8			—
Share based compensation		391			—
Purchase of subsidiary shares from noncontrolling interest		—			(800	)
Sale of subsidiary shares to noncontrolling interest		—			1,603
Net derivative instrument loss, net of tax								(227	)		(411	)
Share-based compensation (adjustment)								97			(389	)
Purchase of subsidiary shares								(17	)		(152	)
Transfer of subsidiary shares purchased								—			54
Dividends		(5,947	)		(4,863	)		(20,301	)		(16,056	)
Noncontrolling interest, end of period		133,844			119,133			178,733			153,191
								788,146			852,671
								113,426			80,811
Total equity	$	562,529		$	507,548		$	846,934		$	723,005

See notes to consolidated financial statements.

Page 5

INTER PARFUMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


	Nine months ended September 30,						Six months ended June 30,
	2017			2016			2023			2022
Cash flows from operating activities:
Net income	$	49,481		$	38,656		$	113,426		$	80,811
Adjustments to reconcile net income to net cash used in operating activities:
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization		7,377			7,113			8,367			6,803
Provision for doubtful accounts		283			231			(650	)		1,241
Share based compensation		1,558			706
Deferred tax benefit		(2,051	)		(2,556	)
Noncash stock compensation								1,265			1,877
Share of income of equity investment								(48	)		(444	)
Noncash lease expense								2,620			3,017
Deferred tax provision (benefit)								(2,987	)		(2,595	)
Change in fair value of derivatives		(1,869	)		314			164			(2,036	)
Changes in:
Accounts receivable		(43,163	)		(48,735	)		(35,181	)		(48,085	)
Inventories		(27,345	)		(4,979	)		(66,144	)		(81,188	)
Other assets		542			71			3,406			(1,872	)
Operating lease liabilities								(2,579	)		(2,822	)
Accounts payable and accrued expenses		(8,145	)		(7,784	)		(23,425	)		7,916
Income taxes, net		7,203			4,391			8,531			8,869

Net cash used in operating activities		(16,129	)		(12,572	)
Net cash provided by (used in) operating activities								6,765			(28,508	)

Cash flows from investing activities:
Purchases of short-term investments		(25,988	)		(48,629	)		(97,079	)		(2,941	)
Proceeds from sale of short-term investments		10,033			15,621			138,061			6,211
Purchases of equipment and leasehold improvements		(2,253	)		(4,260	)
Purchases of property, equipment and leasehold improvements								(3,202	)		(30,305	)
Payment for intangible assets acquired		(764	)		(642	)		(228	)		(1,016	)
Proceeds from sale of trademark		5,886			—

Net cash used in investing activities		(13,086	)		(37,910	)
Net cash provided by (used in) investing activities								37,552			(28,051	)

Cash flows from financing activities:
Repayments of long-term debt		(16,567	)		(16,567	)
Proceeds from exercise of stock options		839			1,235
Proceeds from sale of shares of subsidiary		—			1,449
Proceeds from loans payable, bank								4,947			—
Repayment of long-term debt								(15,958	)		(7,522	)
Proceeds from exercise of options								5,191			810
Purchase of subsidiary shares from noncontrolling interest								—			(4,403	)
Dividends paid		(15,891	)		(13,349	)		(40,020	)		(31,844	)
Dividends paid to noncontrolling interest		(5,947	)		(4,863	)		(20,301	)		(16,056	)
Purchase of stock of subsidiary		—			(2,470	)
Purchase of treasury stock								(11,289	)		—

Net cash used in financing activities		(37,566	)		(34,565	)		(77,430	)		(59,015	)

Effect of exchange rate changes on cash		13,320			4,032			2,711			(578	)

Net decrease in cash and cash equivalents		(53,461	)		(81,015	)		(30,402	)		(116,152	)

Cash and cash equivalents - beginning of period		161,828			176,967			104,713			168,387

Cash and cash equivalents - end of period	$	108,367		$	95,952		$	74,311		$	52,235

Supplemental disclosure of cash flow information:
Cash paid for:
Interest	$	1,351		$	1,758		$	3,189		$	1,581
Income taxes		16,823			18,881			30,096			16,369

See notes to consolidated financial statements.

Page 6

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

Significant Accounting Policies:

The accounting policies we follow are set forth in the notes to our consolidated financial statements included in our Form 10-K, which was filed with the Securities and Exchange Commission for the year ended December 31, ~~2016. We also discuss such policies in Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, included in this Form 10-Q.~~2022.

~~Recent Accounting Pronouncements:~~Impact of COVID-19 Pandemic:

~~In August 2017,~~

Our business has continued to significantly improve throughout 2022 and the ~~Financial Accounting Standards Board (“FASB”) issued an Accounting Standards Update (“ASU”) to improve accounting for hedging activities. The objective~~first half of 2023 after the disastrous effects of the ~~ASU is to improve~~COVID-19 Pandemic starting in early 2020, as retail stores reopened, and consumers increased online purchasing. While COVID-19 had significantly restricted international travel, the financial reporting of hedging relationships in order to better portray the economic results of an entity’s risk management activities in its financial statements and to make certain targeted improvements to simplify the application of hedge accounting guidance. This ASU is effective for annual and interim periods beginning after December 15, 2018 and early adoption is permitted. We are currently evaluating the standard to determine the impact of its adoptiontravel retail business has picked up. Lastly, we experienced significant strains on our ~~consolidated financial statements.~~supply chain causing disruptions affecting the procurement of components, the ability to transport goods, and related cost increases. These disruptions came at a time when demand for our product lines has never been stronger or more sustained. We have addressed this issue since the beginning of 2021, by ordering well in advance of need and in larger quantities. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and when possible, manufacture products closer to where they are sold. The supply chain bottlenecks have been improving and while lead times remain longer than pre-COVID, we do not expect significant disruptions going forward.

Recent Agreements:

Roberto Cavalli

In ~~August 2016,~~July 2023, we closed a transaction agreement with Roberto Cavalli, whereby an exclusive and worldwide license was granted for the ~~FASB issued an ASU~~production and distribution of Roberto Cavalli brand perfumes and fragrance related products. Our rights under this license are subject to ~~eliminate the diversity~~certain minimum advertising expenditures and royalty payments as are customary in ~~practice related to the classification of certain cash receipts~~our industry. The license became effective in July 2023 and ~~payments in the statement of cash flows, by adding or clarifying guidance on eight specific cash flow issues. This ASU is effective~~will last for annual and interim periods beginning after December 15, 2017 and early adoption is permitted. We have evaluated the standard and determined that there will be no material impact on our consolidated financial statements.6.5 years.

Lacoste

In ~~February 2016,~~December 2022, we closed a transaction agreement with Lacoste, whereby an exclusive and worldwide license was granted for the ~~FASB issued an ASU which requires lessees~~production and distribution of Lacoste brand perfumes and cosmetics. Our rights under this license are subject to ~~recognize lease assets~~certain minimum advertising expenditures and ~~lease liabilities arising from operating leases on the balance sheet. This ASU is~~royalty payments as are customary in our industry. The license becomes effective in January 2024 and will last for ~~annual and interim reporting periods beginning after December~~ 15 ~~2018 using a modified retrospective approach, with early adoption permitted. We are currently evaluating the standard to determine the impact of its adoption on our consolidated financial statements.~~years.

Dunhill

In ~~November 2015,~~April 2022, we announced that the ~~FASB~~Dunhill fragrance license will expire on September 30, 2023 and will not be renewed. The Company will continue to produce and sell Dunhill fragrances until the license expires and will maintain the right to sell-off remaining Dunhill fragrance inventory for a limited time as is customary in the fragrance industry.

Page 7

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

Donna Karan and DKNY

In September 2021, we entered into a long-term global licensing agreement for the creation, development and distribution of fragrances and fragrance related products under the Donna Karan and DKNY brands. Our rights under this license are subject to certain minimum advertising expenditures and royalty payments as are customary in our industry. With this agreement, we are gaining several well-established and valuable fragrance franchises, most notably Donna Karan Cashmere Mist and DKNY Be Delicious, as well as a significant loyal consumer base around the world. In connection with the grant of license, we issued ~~an ASU that requires all deferred tax liabilities~~65,342 shares of Inter Parfums, Inc. common stock valued at $5.0 million to the licensor. The exclusive license became effective July 1, 2022, and ~~assets~~we are planning to launch new fragrances under these brands in 2024.

Rochas Fashion

Effective January 1, 2021, we entered into a new license agreement modifying our Rochas fashion business model. The new agreement calls for a reduction in royalties to be ~~classified as noncurrent~~received. As a result, in the first quarter of 2021, we took a $2.4 million impairment charge on our Rochas fashion trademark. In the fourth quarter of 2022, we again took a $6.8 million impairment charge on the ~~balance sheet. This ASU is effective for annual and interim reporting periods beginning~~Rochas fashion trademark after ~~December 15, 2016. In January 2017,~~an independent expert concluded that the Company adopted the standard retrospectively, which resulted in reclassifications among accounts on the consolidated balance sheet, but had no other impact on our results of operations, financial condition or cash flows. The effectvaluation of the ~~adoption on prior periods~~trademark was ~~a reclassification from current assets~~$11.3 million. The new license also contains an option for the licensee to ~~noncurrent assets of approximately $8 million.~~buy-out the Rochas fashion trademarks in June 2025 at its then fair market value.

Land and Building Acquisition - Headquarters in Paris

In ~~May 2014,~~April 2021, Interparfums SA, our 72% owned French Subsidiary, completed the ~~FASB issued~~acquisition of its headquarters at 10 rue de Solférino in the 7th arrondissement of Paris from the property developer. This is an ~~ASU~~office complex combining three buildings connected by two inner courtyards, and consists of approximately 40,000 total sq. ft.

The purchase price included the complete renovation of the site. As of June 30, 2023, $152 million of the purchase price, including approximately $3.1 million of acquisition costs, is included in property, equipment and leasehold improvements on the accompanying balance sheet. The purchase price has been allocated approximately $62.2 million to land and $89.6 million to the building. The building, which ~~superseded~~was delivered on February 28, 2022, includes the ~~most current revenue recognition requirements. This new revenue recognition standard requires entities to recognize revenue in a way~~building structure, development of the property, façade waterproofing, general and technical installations and interior fittings that depicts the transfer of goods or services to customers in an amount that reflects the consideration which the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosure requirements. This guidance is effective for annual and interim reporting periods beginning after December 15, 2017, with early adoption permitted for annual periods after December 31, 2016. We have evaluated the standard and determined that there will be ~~no material impact~~depreciated over a range of 7 to 50 years. The Company has elected to depreciate the building cost based on ~~our consolidated financial statements.~~the useful lives of its components. Approximately $1.2 million of cash held in escrow is also included in property, equipment and leasehold improvements on the accompanying balance sheet as of June 30, 2023.

The acquisition was financed by a 10-year €120 million (approximately $130.4 million) bank loan which bears interest at one-month Euribor plus 0.75%. Approximately €80 million of the variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. The swap effectively exchanges the variable interest rate to a fixed rate of approximately 1.1%.

Recent Accounting Pronouncements:

There are no ~~other~~ recent accounting pronouncements issued but not yet adopted that would have a material effect on our consolidated financial statements.

Page 7 8

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

3.5.

Inventories:

Inventories consist of the following:

(In thousands)	September 30, 2017		December 31, 2016		June 30, 2023		December 31, 2022
Raw materials and component parts	$	43,261	$	36,821	$	173,660	$	146,772
Finished goods		91,019		60,156		186,358		143,212

	$	134,280	$	96,977
Inventories					$	360,018	$	289,984

4.6.

Fair Value Measurement:

The following tables present our financial assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value.

			Fair Value Measurements at September 30, 2017
			Quoted Prices in		Significant Other		Significant
			Active Markets for		Observable		Unobservable
			Identical Assets		Inputs		Inputs				Fair Value Measurements at June 30, 2023
	Total		(Level 1)		(Level 2)		(Level 3)		Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Short-term investments	$	122,402	$	—	$	122,402	$	—	$	112,449	$	2,150	$	109,489	$	811
Interest rate swaps										6,780		—		6,780		—
Foreign currency forward exchange contracts not accounted for using hedge accounting										165		—		165		—

Total asset									$	119,394	$	2,150	$	116,434	$	811
Liabilities:
Foreign currency forward exchange contracts accounted for using hedge accounting		1,230				1,230			$	9	$	—	$	9	$	—

	$	123,632	$	—	$	123,632	$	—
Liabilities:
Interest rate swap	$	628	$	—	$	628	$	—
Foreign currency forward exchange contracts not accounted for using hedge accounting		310		—		310		—
Interest rate swap	$	938	$	—	$	938	$	—

Fair Value Measurements at December 31, 2016
Quoted Prices in Significant Other Significant
Active Markets for Observable Unobservable
Identical Assets Inputs Inputs
Total (Level 1) (Level 2) (Level 3)
Assets:
Short-term investments $ 94,202 $ — $ 94,202 $ —

Liabilities:
Foreign currency forward exchange contracts accounted for using hedge accounting $ 181 $ — $ 181 $ —
Foreign currency forward exchange contracts not accounted for using hedge accounting 418 — 418 —
Interest rate swap 908 — 908 —
$ 1,507 $ — $ 1,507 $ —

Page 8 9

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements


			Fair Value Measurements at December 31, 2022
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Short-term investments	$	150,833	$	19,861	$	130,174	$	798
Interest rate swaps		6,758		—		6,758		—
Foreign currency forward exchange contracts accounted for using hedge accounting		1,189		—		1,189		—

Total asset	$	158,780	$	19,861	$	138,121	$	798
Liabilities:
Foreign currency forward exchange contracts not accounted for using hedge accounting		68		—		68		—

Total Liabilities	$	68	$	—	$	68	$	—

The carrying amount of cash and cash equivalents including money market funds, short-term investments, accounts receivable, other receivables, ~~and~~cash held in escrow, accounts payable and accrued expenses ~~approximates~~approximate fair value due to the short terms to maturity of these instruments.

The carrying amount of loans payable approximates fair value as the interest rates on the Company’s indebtedness approximate current market rates. The fair value of the Company’s long-term debt was estimated based on the current rates offered to companies for debt with the same remaining maturities and is approximately equal to its carrying value.

Foreign currency forward exchange contracts are valued based on quotations from financial institutions and the value of interest rate swaps ~~are~~is the discounted net present value of the swaps using third party quotes ~~obtained~~ from financial institutions.

5.7.

Derivative Financial Instruments:

The Company enters into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency. Before entering into a derivative transaction for hedging purposes, it is determined that a high degree of initial effectiveness exists between the change in value of the hedged item and the change in the value of the derivative instrument from movement in exchange rates. High effectiveness means that the change in the cash flows of the derivative instrument will effectively offset the change in the cash flows of the hedged item. The effectiveness of each hedged item is measured throughout the hedged period and is based on the dollar offset methodology and excludes the portion of the fair value of the foreign currency forward exchange contract attributable to the change in spot-forward difference which is reported in current period earnings. Any hedge ineffectiveness is also recognized as a gain or loss on foreign currency in the income statement. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued, and gains and losses accumulated in other comprehensive income are reclassified to earnings. If it is probable that the forecasted transaction will no longer occur, then any gains or losses accumulated in other comprehensive income are reclassified to current-period earnings.

Page 10

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

In December 2022, to finance the acquisition of the Lacoste trademark, the Company entered into a €50 million (approximately $54.3 million) 4-year term loan with a variable interest rate. This variable rate debt was swapped for variable interest rate debt with a maximum rate of 2% per annum. This swap is a hedged derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in other comprehensive income.

In connection with the ~~May 2015 Rochas brand~~April 2021 acquisition ~~$108~~of the office building complex in Paris, €120 million (approximately $130.4 million) of the purchase price was ~~paid in cash on the closing date and was~~ financed ~~entirely~~ through a ~~5-year~~10-year term loan. ~~As the payment at closing was due in dollars and we had planned to finance it with debt in euro, the~~The Company entered into ~~foreign currency forward~~interest rate swap contracts related to ~~secure~~€80 million of the ~~exchange~~loan, effectively exchanging the variable interest rate ~~for the $108 million purchase price at $1.067 per 1 euro.~~to a fixed rate of approximately 1.1%. This derivative ~~was designated~~instrument is recorded at fair value and ~~qualified as a cash flow hedge.~~changes in fair value are reflected in the accompanying consolidated statements of income.

Gains and losses in derivatives designated as hedges are accumulated in other comprehensive income ~~(loss)~~ and gains and losses in derivatives not designated as hedges are included in (gain) loss on foreign currency on the accompanying income statements. Such gains and losses were immaterial for the ~~nine~~three and six months ended ~~September~~June 30, ~~2017~~2023 and ~~2016. Interest expense includes a gain (loss) of $0.4 million and ($0.2) million for the nine months ended September 30, 2017 and 2016 respectively, relating to the interest rate swap.~~2022.

All derivative instruments are reported as either assets or liabilities on the balance sheet measured at fair value. The valuation of interest rate swaps ~~as of September 30, 2017, resulted in a liability which~~ is included in ~~long-term debt~~other assets on the accompanying balance sheets. The valuation of foreign currency forward exchange contracts ~~not accounted for using hedge accounting~~ at ~~September~~June 30, ~~2017,~~2023 resulted in a ~~liability~~net asset and is included in ~~accrued expenses~~other current assets on the accompanying balance sheet.

~~Page 9~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

At ~~September~~June 30, ~~2017,~~2023, we had foreign currency contracts in the form of forward exchange contracts in the amount of approximately U.S. ~~$22.6~~$38.0 million and GB ~~£11.5~~£2.0 million which ~~both~~all have maturities of less than one year.

6.8.

~~Accrued Expenses:~~Leases:

~~Accrued expenses include approximately $20.6~~The Company leases its offices and warehouses, vehicles, and certain office equipment, substantially all of which are classified as operating leases. The Company currently has no material financing leases. The Company determines if an arrangement is a lease at inception. Operating lease assets and obligations are recognized at the lease commencement date based on the present value of lease payments over the lease term.

In determining lease asset value, the Company considers fixed or variable payment terms, prepayments, incentives, and options to extend or terminate, depending on the lease. Renewal, termination, or purchase options affect the lease term used for determining lease asset value only if the option is reasonably certain to be exercised. The Company generally uses its incremental borrowing rate based on information available at the lease commencement date for the location in which the lease is held in determining the present value of lease payments.

Page 11

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

As of June 30, 2023, the weighted average remaining lease term was 5.6 years and the weighted average discount rate used to determine the operating lease liability was 2.8%. Rental expense related to operating leases was $1.5 million and $2.9 million for the three and six months ended June 30, 2023, respectively, as compared to $1.3 million and ~~$14.1~~$3.1 million for the corresponding periods of the prior year. Operating lease payments included in ~~advertising liabilities as of September~~operating cash flows totaled $2.6 million and $2.8 million for the six months ended June 30, ~~2017~~2023 and ~~December 31, 2016,~~2022, respectively, and noncash additions to operating lease assets totaled $2.4 million and $0.5 million for the six months ended June 30, 2023 and 2022, respectively.

7.9.

~~Share Based~~Share-Based Payments:

The Company maintains a stock option ~~programs~~program for key employees, executives and directors. The plans, all of which have been approved by shareholder vote, provide for the granting of both nonqualified and incentive options. Options granted under the plans typically have a six-year term and vest over a four to ~~five-year~~five-year period. The fair value of shares vested ~~for both~~during the ~~nine~~six months ended ~~September~~June 30, ~~2017~~2023 and ~~2016~~2022 aggregated ~~$0.05 million.~~$0.10 million and $0.10 million, respectively. Compensation cost, net of forfeitures, is recognized on a straight-line basis over the requisite service period for the entire award. Forfeitures are estimated based on historic trends. It is generally our policy to issue new shares upon exercise of stock options.

The following table sets forth information with respect to nonvested options for the ~~nine month period~~six months ended ~~September~~June 30, ~~2017:~~2023:

	Number of Shares			Weighted Average Grant Date Fair Value		Number of Shares			Weighted Average Grant-Date Fair Value
Nonvested options – beginning of period		401,440		$	7.14		168,730		$	16.31
Nonvested options granted		7,000		$	8.04		—			—
Nonvested options vested or forfeited		(18,145	)	$	7.01		(23,560	)	$	13.59
Nonvested options – end of period		390,295		$	7.16		145,170		$	16.75

~~Share based~~Share-based payment expense decreased income before income taxes by ~~$0.54~~$0.63 million and ~~$1.56~~$1.27 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2017,~~2023, respectively, as compared to ~~$0.28~~$1.22 million and ~~$0.70~~$1.88 million for the corresponding periods of the prior year. ~~Share based~~Share-base income before income d payment expense decreased income attributable to Inter Parfums, Inc. by ~~$0.29~~$0.43 million and ~~$0.86~~$0.86 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2017,~~2023, respectively, as compared to ~~$0.16~~$0.74 million and ~~$0.42~~$1.18 million for the corresponding periods of the prior year.

The following table summarizes stock option information as of ~~September~~June 30, ~~2017:~~2023:

	Shares			Weighted Average Exercise Price		Shares			Weighted Average Exercise Price

Outstanding at January 1, 2017		684,540		$	26.94
Options granted		7,000			35.72
Outstanding at January 1, 2023							441,580		$	67.30
Options forfeited		(12,080	)		29.70		(15,960	)		70.48
Options exercised		(44,140	)		19.02		(93,430	)		55.57

Outstanding at September 30, 2017		635,320		$	27.54
Outstanding at June 30, 2023							332,190		$	70.44

Options exercisable		245,025		$	25.13		187,020		$	61.53
Options available for future grants		1,086,735					574,935

Page 10 12

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

As of ~~September~~June 30, ~~2017,~~2023, the weighted average remaining contractual life of options outstanding is ~~3.23~~2.40 years ~~(1.99~~(0.6 years for options exercisable),; the aggregate intrinsic value of options outstanding and options exercisable is ~~$8.7~~$21.5 million and ~~$4.0~~$13.8 million, ~~respectively,~~respectively; and unrecognized compensation cost related to stock options outstanding aggregated ~~$2.2~~$2.0 million.

Cash proceeds, tax benefits and intrinsic value related to stock options exercised during the ~~nine~~six months ended ~~September~~June 30, ~~2017~~2023 and ~~September 30, 2016~~2022 were as follows:

(In thousands)	September 30, 2017		September 30, 2016		June 30, 2023		June 30, 2022

Cash proceeds from stock options exercised	$	839	$	1,235	$	5,192	$	810
Tax benefits		135		—		840		75
Intrinsic value of stock options exercised		804		947		5,773		698

~~The weighted average fair values of the~~There were no options granted ~~by Inter Parfums, Inc.~~ during the ~~nine~~six months ended ~~September~~June 30, ~~2017~~2023 and ~~2016 were $8.04 and $6.50 per share, respectively, on the date of grant using the Black-Scholes option pricing model to calculate the fair value of options granted.~~

~~The assumptions used in the Black-Scholes pricing model for the periods ended September~~June 30, ~~2017 and 2016 are set forth in the following table:~~2022.

September 30,
2017 September 30,
2016

Weighted average expected stock-price volatility 29 % 33 %
Weighted average expected option life 5 years 5 years
Weighted average risk-free interest rate 1.9 % 1.4 %
Weighted average dividend yield 2.1 % 2.2 %

Expected volatility is estimated based on historic volatility of the Company’s common stock. The expected term of the option is estimated based on historic data. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant of the option and the dividend yield reflects the assumption that the dividend payout as authorized by the Board of Directors would increase as the earnings of the Company and its stock price ~~increases.~~continues to increase.

In ~~September 2016,~~December 2018, Interparfums SA ~~our 73% owned subsidiary in Paris,~~ approved a plan to grant an aggregate of ~~15,100~~26,600 shares of its stock to employees with no performance condition requirement, and an aggregate of 133,000 shares to officers and managers, subject to certain corporate performance conditions. The corporate performance conditions were met and therefore in June 2022, 211,955shares, adjusted for stock splits, were distributed. The aggregate cost of the grant of approximately $4.8 million was recognized as compensation cost on a straight-line basis over the requisite three-year service period.

In March 2022, Interparfums SA approved an additional plan to grant an aggregate of 88,400 shares to all Interparfums SA employees and corporate officers having more than six months of employment at grant date, subject to certain corporate performance conditions. The shares, subject to adjustment for stock splits, will be distributed in ~~September 2019 so long~~June 2025 and will follow the same guidelines as the individual is employed by Interparfums SA at the time, and in the case of officers and managers, only to the extent that the performance conditions have been met. Once distributed, the shares will be unrestricted and the employees will be permitted to trade their shares.

~~Page 11~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~December 2018 plan.

The fair value of the grant ~~of €22.46 per share (approximately $26.50 per share) has~~had been determined based on the quoted ~~share~~stock price of Interparfums SA shares as reported by the NYSE Euronext on the date of grant. The estimated number of shares to be distributed of ~~137,381~~93,489 has been determined taking into account employee turnover. The aggregate cost of the grant of ~~€3.1~~approximately $4.2 million ~~(approximately $3.7 million)~~ will be recognized as compensation cost ~~by Interparfums SA~~ on a straight-line basis over the requisite three and a quarter year service period. ~~For the nine months ended September 30, 2017, $0.9 million of compensation cost has been recognized in connection with this plan.~~

ToSimilar to the December 2018 plan, in order to avoid dilution of the Company’s ownership of Interparfums SA, all shares distributed or to be distributed pursuant to ~~this plan~~these plans will be pre-existing shares of Interparfums SA, purchased in the open market by Interparfums SA. As of ~~December 31, 2016, 108,348~~June 30, 2023 the Company acquired 69,609 shares ~~have been acquired in the open market~~ at an aggregate cost of ~~$2.9 million, and such amount has been~~$3.0 million.

In the first half of 2023, the Company initiated a share repurchase program with the primary intent of neutralizing the dilution impact of the stock option programs previously discussed. Over the course of the first half of 2023, the Company repurchased 85,060 shares at a cost of $11.3 million. These shares are classified as ~~an equity transaction~~treasury shares on the accompanying balance sheet. ~~No additional~~The Company plans to continue repurchasing shares ~~were purchased during~~throughout 2023.

Page 13

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

All share purchases and issuances have been classified as equity transactions on the ~~nine months ended September 30, 2017.~~accompanying balance sheet.

8.10.

Net Income Attributable to Inter Parfums, Inc. Common Shareholders:

Net income attributable to Inter Parfums, Inc. per common share (“basic EPS”) is computed by dividing net income attributable to Inter Parfums, Inc. by the weighted average number of shares outstanding. Net income attributable to Inter Parfums, Inc. per share assuming dilution (“diluted EPS”), is computed using the weighted average number of shares outstanding, plus the incremental shares outstanding assuming the exercise of dilutive stock options using the treasury stock method.

The reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows:

Three months ended Nine months ended
(In thousands) September 30, September 30,
2017 2016 2017 2016
Numerator:
Net income attributable to Inter Parfums, Inc. $ 17,077 $ 16,239 $ 37,194 $ 29,404
Denominator:
Weighted average shares 31,175 31,080 31,163 31,058
Effect of dilutive securities:
Stock options 132 91 118 80
Denominator for diluted earnings per share 31,307 31,171 31,281 31,138

Earnings per share:
Net income attributable to Inter Parfums, Inc. common shareholders:
Basic $ 0.55 $ 0.52 $ 1.19 $ 0.95
Diluted 0.55 0.52 1.19 0.94


	Three months ended June 30,				Six months ended June 30,
(In thousands)	2023		2022		2023		2022
Numerator:
Net income attributable to Inter Parfums, Inc.	$	34,952	$	27,617	$	89,020	$	62,916
Denominator:
Weighted average shares		32,006		31,845		32,012		31,843
Effect of dilutive securities:
Stock options		156		107		149		138
Denominator for diluted earnings per share		32,162		31,952		32,161		31,981

Earnings per share:
Net income attributable to Inter Parfums, Inc. common shareholders:
Basic	$	1.09	$	0.87	$	2.78	$	1.98
Diluted		1.09		0.86		2.77		1.97

~~Not included in the above computations is the effect of~~There were no antidilutive potential common shares ~~which consist of~~ outstanding options to purchase 0.22 million shares and 0.31 million shares of common stock for the nine months ended September 30, 2017 and 2016, respectively, and 0.15 million and 0.25 million shares of common stock for the three and six months ended ~~September~~June 30, ~~2017~~2023 and ~~2016, respectively.~~June 30, 2022.

Page 12 14

INTER PARFUMS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

9.11.

Segment and Geographic Areas:

The Company manufactures and distributes one product line, fragrances and fragrance related products. The Company manages its business in two segments, European based operations and United States based operations. The European assets are located, and operations are primarily conducted, in France. Both European based operations and United States based operations primarily represent the sale of prestige brand name fragrances.

Information on our operations by geographical areas is as follows:

													Three months ended June 30,					Six months ended June 30,
(In thousands)	Three months ended September 30,						Nine months ended September 30,						2023		2022			2023		2022
	2017			2016			2017			2016
Net sales:
United States	$	35,690		$	34,251		$	81,977		$	82,197		$	111,436	$	78,444		$	192,890	$	146,946
Europe		134,639			123,405			361,172			304,217			197,808		166,287			428,077		348,469
Eliminations		(798	)		(34	)		(1,424	)		(113	)		—		(6	)		—		(12	)

	$	169,531		$	157,622		$	441,725		$	386,301		$	309,244	$	244,725		$	620,967	$	495,403

Net income attributable to Inter Parfums, Inc.:
United States	$	3,668		$	2,850		$	5,134		$	4,804		$	15,567	$	9,991		$	25,910	$	16,505
Europe		13,409			13,389			32,060			24,600			19,385		17,626			63,110		46,411

	$	17,077		$	16,239		$	37,194		$	29,404		$	34,952	$	27,617		$	89,020	$	62,916

(In thousands) September 30, December 31,
2017 2016
Total Assets:
United States $ 98,747 $ 89,930
Europe 676,519 602,077
Eliminations of investment in subsidiary (9,593 ) (9,598 )

$ 765,673 $ 682,409

~~10.~~

~~Other Matters~~

	June 30,			December 31,
	2023			2022
Total Assets:
United States	$	313,261		$	278,090
Europe		1,048,040			1,052,004
Eliminations		(9,637	)		(21,552	)
	$	1,351,664		$	1,308,542

~~License Renewal:~~

In May 2017, the Company, through its majority owned Paris based subsidiary, Interparfums SA, renewed its license agreement for an additional four years with Paul Smith for the creation, development, and distribution of fragrance products through December 2021, without any material changes in terms and conditions. Our initial 12-year license agreement with Paul Smith was signed in 1998, and had previously been extended through December 31, 2017.

Page 13 15

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~

~~Notes to Consolidated Financial Statements~~

~~Buyout of License:~~

In December 2016, the Company reached an agreement with the Balmain brand calling for Balmain to buyout the Balmain license agreement, effective December 31, 2016, in exchange for a payment aggregating $5.9 million. As a result of the buyout, the Company recognized a gain of $4.7 million as of December 31, 2016, and received the buyout payment in May 2017. As of March 31, 2017, the three month inventory sell-off period concluded and Balmain purchased all remaining inventory aggregating $1.4 million.

~~Settlement with French Tax Authorities:~~

As previously reported, the French Tax Authorities examined the 2012 tax return of Interparfums SA, and in August 2015 issued a $6.9 million tax adjustment. The main issues challenged by the French Tax Authorities related to the commission rate and royalty rate paid to Interparfums Singapore Pte. and Interparfums (Suisse) SARL, respectively. Due to the subjective nature of the issues involved, in April 2016, Interparfums SA reached an agreement in principle to settle the entire matter with the French Tax Authorities. The settlement required Interparfums SA to pay a tax assessment of $1.9 million covering the issues for not only the 2012 tax year, but also covering the issues for the tax years ended 2013 through 2015. The settlement, which was finalized by the French Tax Authorities in the first quarter of 2017, was accrued in March 2016.

~~11.~~

~~Subsequent Event~~

In 2012, the French government introduced a 3% tax on dividends or deemed dividends for entities subject to French corporate income tax. On October 6, 2017 the French Constitutional Court released a decision declaring that the 3% tax on dividends or deemed dividends is unconstitutional. As a result of that decision, the Company has filed a claim for refund of approximately $3.3 million (€2.8 million) for these taxes paid since 2015. The French government has not yet determined if, how, or when they will reimburse companies who have filed claims. There is even discussion of additional tax measures to offset this cost. Therefore, due to the unknown factors involved in the potential reimbursement of the claim, the Company did not recognize the refund claim in the accompanying financial statements as of September 30, 2017. The Company will continue to monitor future events as they relate to this matter.

~~Page 14~~

INTER PARFUMS, INC. AND SUBSIDIARIES

Item 2:

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Information

Statements in this report which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will” and “would” or similar words. You should not rely on forward-looking statements because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and “Risk Factors” in Inter Parfums’ annual report on Form 10-K for the fiscal year ended December 31, ~~2016~~2022, and the reports Inter Parfums files from time to time with the Securities and Exchange ~~Commission.~~Commission (“SEC”). Inter Parfums does not intend to and undertakes no duty to update the information contained in this report.

~~Regulation S-K Item 10(e)~~

Regulation S-K Item 10(e), “Use of Non-GAAP Financial Measures in commission filings,” prescribes the conditions for use of non-GAAP financial information in commission filings. Our reported results for the nine months ended September 30, 2016, include a provision of $1.9 million ($1.4 million net of noncontrolling interests) for income taxes resulting from a nonrecurring tax settlement. Due to the significance of this transaction, as well as its nonrecurring nature, exclusion of such amount in the non-GAAP financial measures provides a more complete disclosure and facilitates a more accurate comparison of current results to historic results. Based upon the foregoing, we believe that our presentation of the non-GAAP financial information beginning on page 27 of this Form 10-Q is an important supplemental measure of operating performance to investors.

Overview

We operate in the fragrance business, and manufacture, market and distribute a wide array of fragrances and fragrance related products. We manage our business in two segments, European based operations and United States based operations. Certain prestige fragrance products are produced and marketed by our European operations through our ~~73%~~72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as ~~27%~~28% of Interparfums SA shares trade on the NYSE Euronext.

We produce and distribute our European based fragrance products primarily under license agreements with brand owners, and European based fragrance product sales represented approximately ~~82%~~69% and ~~79%~~70% of net sales for the ~~nine~~six months ended ~~September~~June 30, ~~2017~~2023 and ~~2016,~~2022, respectively. We have built a portfolio of prestige brands, which includeBoucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, ~~Paul Smith, Repetto, Rochas,~~ S.T. Dupont, Rochas andVan Cleef & Arpels, whose products are distributed in over ~~100~~120 countries around the world.

~~Page 15~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~

~~With respect to~~ In addition, our ~~largest brands, we own the Lanvin brand name for its class of trade,~~exclusive and worldwide license ~~the Montblanc and Jimmy Choo brand names;~~ for the ~~nine months ended September 30, 2017, sales~~production and distribution of ~~product for these brands represented 12%, 22%,~~Lacoste brand perfumes and ~~20% of net sales, respectively.~~cosmetics becomes effective in January 2024.

Through our United States operations, we also market fragrance and fragrance related products. United States operations represented ~~18%~~31% and ~~21%~~30% of net sales for the ~~nine~~six months ended ~~September~~June 30, ~~2017~~2023 and ~~2016,~~2022, respectively. These fragrance products are sold primarily pursuant to license or other agreements with the owners of theAbercrombie & Fitch, ~~Agent Provocateur,~~ Anna Sui, ~~bebe, Dunhill, French Connection,~~Donna Karan, DKNY, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Rentaand~~Shanghai Tang~~Ungaro brands. In addition, our exclusive and worldwide license for the production and distribution of Roberto Cavalli brand perfumes and fragrance related products became effective in July 2023.

Page 16

INTER PARFUMS, INC. AND SUBSIDIARIES

Substantially all of our prestige fragrance brands are licensed from unaffiliated third parties, and our business is dependent upon the continuation and renewal of such licenses. With respect to the Company’s largest brands, we license the Montblanc, Coach, Jimmy Choo and GUESS brand names.

As a percentage of net sales, product sales for the Company’s largest brands were as follows:

	Six Months Ended June 30,
	2023			2022

Montblanc		19	%		19	%
Jimmy Choo		18	%		15	%
Coach		15	%		15	%
GUESS		11	%		12	%

Quarterly sales fluctuations are influenced by the timing of new product launches as well as the third and fourth quarter holiday season. In certain markets where we sell directly to retailers, seasonality is more evident. We primarily sell directly to retailers in France ~~as well as through our own distribution subsidiaries in Italy, Germany, Spain~~ and the United States.

We grow our business in two distinct ways. First, we grow by adding new brands to our portfolio, ~~either~~ through new licenses, or other arrangements or out-right acquisitions of brands. Second, we grow through the introduction of new products and by supporting new and established products through advertising, merchandising and sampling as well as phasing out underperforming products so we can devote greater resources to those products with greater potential. The economics of developing, producing, launching and supporting products influence our sales and operating performance each year. Our introduction of new products may have some cannibalizing effect on sales of existing products, which we take into account in our business planning.

Our business is not capital intensive, and it is important to note that we do not own manufacturing facilities. We act as a general contractor and source our needed components from our suppliers. These components are received at one of our distribution centers and then, based upon production needs, the components are sent to one of several ~~third party~~third-party fillers, which manufacture the finished product for us and then deliver them to one of our distribution centers.

As with any global business, many aspects of our operations are subject to influences outside our control. We believe we have a strong brand portfolio with global reach and potential. As part of our strategy, we plan to continue to make investments behind fast-growing markets and channels to grow market share.

For the past several years, the economic and political uncertainty and financial market volatility in Eastern Europe, the Middle East and China had a minor negative impact on our business, however our sales in these regions have been improving and we do not anticipate dramatic changes in business conditions for the foreseeable future. However, if the degree of uncertainty or volatility worsens or is prolonged, then there will likely be a negative effect on ongoing consumer confidence, demand and spending and accordingly, our business. We believe general economic and other uncertainties still exist in select markets in which we do business, and we monitor these uncertainties and other risks that may affect our business.

~~Page 16~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~

Our reported net sales are impacted by changes in foreign currency exchange rates. A strong U.S. dollar has a negative impact on our net sales. However, ~~gross margins~~earnings are positively affected by a strong dollar, because almost ~~45%~~50% of net sales of our European operations are denominated in U.S. dollars, while almost all costs of our European operations are incurred in euro. Conversely, a weak U.S. dollar has a favorable impact on our net sales while gross margins are negatively affected. ~~Our Company addresses~~We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial ~~instruments. We~~instruments and primarily enter into foreign currency forward exchange contracts to reduce the effects of fluctuating foreign currency exchange rates. We are also carefully monitoring currency trends in the United Kingdom as a result of the volatility created from the United Kingdom’s decision to exit the European Union. We have evaluated our current pricing models and currently we do not expect any significant pricing changes. However, if the devaluation of the British Pound worsens, it may affect future gross profit margins from sales in that territory.

~~Recent Important Events~~

~~Subsequent Event~~

~~License Renewal~~

~~Buyout of License~~

In December 2016, the Company reached an agreement with the Balmain brand calling for Balmain to buyout the Balmain license agreement, effective December 31, 2016, in exchange for a payment aggregating $5.7 million. As a result of the buyout, the Company recognized a gain of $4.7 million as of December 31, 2016, and received the buyout payment in May 2017. As of March 31, 2017, the three month inventory sell-off period concluded and Balmain purchased all remaining inventory aggregating $1.4 million.

Page 17

INTER PARFUMS, INC. AND SUBSIDIARIES

~~Settlement with French Tax Authorities~~Impact of COVID-19 Pandemic

~~As previously reported,~~Please see our discussion of the ~~French Tax Authorities examined~~Impact of the ~~2012 tax return of Interparfums SA, and in August 2015 issued a $6.9 million tax adjustment. The main issues challenged~~COVID-19 Pandemic, which is incorporated by ~~the French Tax Authorities related~~reference to note 2 to the ~~commission rate and royalty rate paid~~Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q for the quarter ended June 30, 2023.

Recent Important Events

Please see our discussion of Recent Important Events, which is incorporated by reference to ~~Interparfums Singapore Pte. and Interparfums (Suisse) SARL, respectively. Due~~note 3 to the ~~subjective nature of the issues involved,~~Consolidated Financial Statements contained in April 2016, Interparfums SA reached an agreement in principle to settle the entire matter with the French Tax Authorities. The settlement required Interparfums SA to pay a tax assessment of $1.9 million covering the issues for not only the 2012 tax year, but also covering the issuesthis Quarterly Report on Form 10-Q for the ~~tax years~~quarter ended ~~2013 through 2015. The settlement, which was finalized by the French Tax Authorities in the first quarter of 2017, was accrued in March 2016.~~June 30, 2023.

Discussion of Critical Accounting Policies

~~We make estimates and assumptions in the preparation of~~Information regarding our financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our most critical accounting policies ~~which are those that are most important to the portrayal of~~can be found in our financial condition and results of operations. These accounting policies generally require our management’s most difficult and subjective judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Management of the Company has discussed the selection of significant accounting policies and the effect of estimates2022 Annual Report on Form 10-K filed with the ~~Audit Committee of the Board of Directors.~~

~~Revenue Recognition~~

We sell our products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors. Sales of such products by our domestic subsidiaries are denominated in U.S. dollars and sales of such products by our foreign subsidiaries are primarily denominated in either euro or U.S. dollars. We recognize revenues when merchandise is shipped and the risk of loss passes to the customer. Net sales are comprised of gross revenues less returns, trade discounts and allowances.

~~Accounts Receivable~~

Accounts receivable represent payments due to the Company for previously recognized net sales, reduced by allowances for sales returns and doubtful accounts. Accounts receivable balances are written-off against the allowance for doubtful accounts when they become uncollectible. Recoveries of accounts receivable previously recorded against the allowance are recorded in the consolidated statement of income when received. We generally grant credit based upon our analysis of the customer’s financial position as well as previously established buying patterns.

~~Page 18~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~

~~Sales Returns~~

Generally, we do not permit customers to return their unsold products. However, for U.S. distribution of our prestige products, we allow returns if properly requested, authorized and approved. We regularly review and revise, as deemed necessary, our estimate of reserves for future sales returns based primarily upon historic trends and relevant current data, including information provided by retailers regarding their inventory levels. In addition, as necessary, specific accruals may be established for significant future known or anticipated events. The types of known or anticipated events that we have considered, and will continue to consider, include, but are not limited to, the financial condition of our customers, store closings by retailers, changes in the retail environment and our decision to continue to support new and existing products. We record estimated reserves for sales returns as a reduction of sales, cost of sales and accounts receivable. Returned products are recorded as inventories and are valued based upon estimated realizable value. The physical condition and marketability of returned products are the major factors we consider in estimating realizable value. Actual returns, as well as estimated realizable values of returned products, may differ significantly, either favorably or unfavorably, from our estimates, if factors such as economic conditions, inventory levels or competitive conditions differ from our expectations.

~~Inventories~~

Inventories are stated at the lower of cost and net realizable value. Cost is principally determined by the first-in, first-out method. We record adjustments to the cost of inventories based upon our sales forecast and the physical condition of the inventories. These adjustments are estimates, which could vary significantly, either favorably or unfavorably, from actual results if future economic conditions or competitive conditions differ from our expectations.

~~Equipment and Other Long-Lived Assets~~

Equipment, which includes tools and molds, is recorded at cost and is depreciated on a straight-line basis over the estimated useful lives of such assets. Changes in circumstances such as technological advances, changes to our business model or changes in our capital spending strategy can result in the actual useful lives differing from our estimates. In those cases where we determine that the useful life of equipment should be shortened, we would depreciate the net book value in excess of the salvage value, over its revised remaining useful life, thereby increasing depreciation expense. Factors such as changes in the planned use of equipment, or market acceptance of products, could result in shortened useful lives.

We evaluate indefinite-lived intangible assets for impairment at least annually during the fourth quarter, or more frequently when events occur or circumstances change, such as an unexpected decline in sales, that would more likely than not indicate that the carrying value of an indefinite-lived intangible asset may not be recoverable. When testing indefinite-lived intangible assets for impairment, the evaluation requires a comparison of the estimated fair value of the asset to the carrying value of the asset. The fair values used in our evaluations are estimated based upon discounted future cash flow projections using a weighted average cost of capital of 6.2%. The cash flow projections are based upon a number of assumptions, including, future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. If the carrying value of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recorded.

~~Page 19~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~

We believe that the assumptions we have made in projecting future cash flows for the evaluations described above are reasonable and currently no impairment indicators exist for our indefinite-lived intangible assets. However, if future actual results do not meet our expectations, we may be required to record an impairment charge, the amount of which could be material to our results of operations.

At December 31, 2016 indefinite-lived intangible assets aggregated approximately $116 million. The following table presents the impact a change in the following significant assumptions would have had on the calculated fair value in 2016 assuming all other assumptions remained constant:

$ in millions Increase (decrease)
Change to fair value

Weighted average cost of capital +10 % $ (16.2 )
Weighted average cost of capital -10 % $ 20.0
Future sales levels +10 % $ 17.0
Future sales levels -10 % $ (17.0 )

Intangible assets subject to amortization are evaluated for impairment testing whenever events or changes in circumstances indicate that the carrying amount of an amortizable intangible asset may not be recoverable. If impairment indicators exist for an amortizable intangible asset, the undiscounted future cash flows associated with the expected service potential of the asset are compared to the carrying value of the asset. If our projection of undiscounted future cash flows is in excess of the carrying value of the intangible asset, no impairment charge is recorded. If our projection of undiscounted future cash flows is less than the carrying value of the intangible asset, an impairment charge would be recorded to reduce the intangible asset to its fair value. The cash flow projections are based upon a number of assumptions, including future sales levels and future cost of goods and operating expense levels, as well as economic conditions, changes to our business model or changes in consumer acceptance of our products which are more subjective in nature. In those cases where we determine that the useful life of long-lived assets should be shortened, we would amortize the net book value in excess of the salvage value (after testing for impairment as described above), over the revised remaining useful life of such asset thereby increasing amortization expense. We believe that the assumptions we have made in projecting future cash flows for the evaluations described above are reasonable.

In determining the useful life of our Lanvin brand names and trademarks, we applied the provisions of ASC topic 350-30-35-3. The only factor that prevented us from determining that the Lanvin brand names and trademarks were indefinite life intangible assets was Item c. “Any legal, regulatory, or contractual provisions that may limit the useful life.” The existence of a repurchase option in 2025 may limit the useful life of the Lanvin brand names and trademarks to the Company. However, this limitation would only take effect if the repurchase option were to be exercised and the repurchase price was paid. If the repurchase option is not exercised, then the Lanvin brand names and trademarks are expected to continue to contribute directly to the future cash flows of our Company and their useful life would be considered to be indefinite.

~~Page 20~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~

With respect to the application of ASC topic 350-30-35-8, the Lanvin brand names and trademarks would only have a finite life to our Company if the repurchase option were exercised, and in applying ASC topic 350-30-35-8, we assumed that the repurchase option is exercised. When exercised, Lanvin has an obligation to pay the exercise price and the Company would be required to convey the Lanvin brand names and trademarks back to Lanvin. The exercise price to be received (Residual Value) is well in excess of the carrying value of the Lanvin brand names and trademarks, therefore no amortization is required.

~~Derivatives~~

We account for derivative financial instruments in accordance with ASC topic 815, which establishes accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and for hedging activities. This topic also requires the recognition of all derivative instruments as either assets or liabilities on the balance sheet and that they are measured at fair value.

We currently use derivative financial instruments to hedge certain anticipated transactions and interest rates, as well as receivables denominated in foreign currencies. We do not utilize derivatives for trading or speculative purposes. Hedge effectiveness is documented, assessed and monitored by employees who are qualified to make such assessments and monitor the instruments. Variables that are external to us such as social, political and economic risks may have an impact on our hedging program and the results thereof.

~~Income Taxes~~

The Company accounts for income taxes using an asset and liability approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in its financial statements or tax returns. The net deferred tax assets assume sufficient future earnings for their realization, as well as the continued application of currently anticipated tax rates. Included in net deferred tax assets is a valuation allowance for deferred tax assets, where management believes it is more-likely-than-not that the deferred tax assets will not be realized in the relevant jurisdiction. If the Company determines that a deferred tax asset will not be realizable, an adjustment to the deferred tax asset will result in a reduction of net income at that time. In addition, the Company follows the provisions of uncertain tax positions as addressed in ASC topic 740.

~~Page 21~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~SEC.

Results of Operations

Three and ~~Nine~~Six Months Ended ~~September~~June 30, ~~2017~~2023 as Compared to the Three and ~~Nine~~Six Months Ended ~~September~~June 30, ~~2016~~2022

Net ~~Sales~~Sales:

(In millions)
Three months ended
September 30,

Nine months ended
September 30,

2017 2016 % Change 2017 2016 % Change
(in millions)
European based brand product sales $ 134.6 $ 123.4 9.1 % $ 361.0 $ 304.1 18.7 %
United States based product sales 34.9 34.2 2.0 % 80.7 82.2 (1.8 )%
Total net sales $ 169.5 $ 157.6 7.6 % $ 441.7 $ 386.3 14.3 %

(in millions)	Three months ended June 30,							Six months ended June 30,
	2023		2022		% Change			2023		2022		% Change

European based product sales	$	197.8	$	166.3		19.0	%	$	428.1	$	348.5		22.8	%
United States based product sales		111.5		78.4		42.1	%		192.9		146.9		31.3	%
	$	309.3	$	244.7		26.4	%	$	621.0	$	495.4		25.3	%

Net sales for the three months ended ~~September~~June 30, ~~2017~~2023, increased ~~7.6% to $169.5 million, as compared to $157.6 million for~~26% from the ~~corresponding period of the prior year.~~three months ended June 30, 2022. At comparable foreign currency exchange rates, net sales increased ~~5.2%.~~25% from the second quarter of 2022. The average dollar/euro exchange rate for the current second quarter was 1.09 compared to 1.06 in the second quarter of 2022, while for the first half of 2023, the average dollar/euro exchange rate was 1.08 compared to 1.09 in the first half of 2022. Net sales for the ~~nine~~six months ended ~~September~~June 30, ~~2017~~2023 increased ~~14.3% to $441.7 million,~~25% as compared to ~~$386.3 million~~the first half of 2022. At comparable foreign currency exchange rates, net sales increased 26% from the first half of 2022.

Continuing the trend from the first quarter 2023, the current second quarter was exceptionally strong for both European and United States based operations, as net sales increased 19% and 42%, respectively, as compared to the corresponding period of the prior year. ~~There was no discernible effect on net sales from changes in foreign currency exchange rates for the nine month period.~~

European based product sales increased 9.1% and 18.7% for the three and nine months ended September 30, 2017, respectively, as compared to the corresponding periods of the prior year. Montblanc, our largest brand, generated sales of $37.2 million and $99.0 million for the three and nine months ended September 30, 2017, respectively, representing an increase of 13% and 5%, as compared to the corresponding periods of the prior year. The 5% increase in nine month 2017 Montblanc product sales reflects the difficult period comparison, as we achieved a 23% increase in 2016 nine months sales when we launched our highly successful scent,~~Montblanc Legend Spirit~~. Our second largest brand, Jimmy Choo, generated sales of $28.2 million and $87.6 million for the three and nine months ended September 30, 2017, respectively, representing an increase of 3% and 24%, as compared to the corresponding periods of the prior year. The increase is due to two recent extensions,~~Jimmy Choo L’Eau~~ ~~for women and~~~~Jimmy Choo Man Ice,~~as well as from solid sales of the brand’s established collections for men and women. Lanvin brand sales, although down 8% for the 2017 third quarter, are up 14% year-to-date resulting from gains in the brand’s best performing product line,~~Éclat d’Arpège,~~ ~~coupled with the international launch of~~~~Modern Princess~~~~. Lanvin brand sales aggregated $19.4 million and $52.4 million for the three and nine months ended September 30, 2017, respectively.~~

The excellent performance of our two newest brands, Coach and Rochas, is especially gratifying. Coach brand sales rose 34% over the comparable period last year and aggregated $18.6 million and $35.2 million for the three and nine months ended September 30, 2017, respectively. Strong sales of the Coach women’s line which rolled out in 2016, combined with the recent launch of the brand’s signature scent for men, generated the exceptional brand sales growth. Rochas fragrance sales aggregated $9.3 million and $29.6 million for the three and nine months ended September 30, 2017, respectively, representing an increase of 33% and 32%, as compared to the corresponding periods of the prior year. The dramatic increase in Rochas fragrance sales was primarily attributable to the strength of the~~Eau de Rochas~~ ~~line and the successful rollout of~~~~Mademoiselle Rochas~~ ~~in approximately fifteen markets thus far.~~

Page 22 18

INTER PARFUMS, INC. AND SUBSIDIARIES

~~United States~~

For European based ~~product~~operations, our largest brands, Coach, Jimmy Choo, and Montblanc sales ~~increased 2.0%~~rose 28%, 21% and ~~decreased 1.8% for the three and nine months ended September 30, 2017,~~16%, respectively, as compared to the corresponding periods of the prior year. The quarterly and year-to-date comparisons are particularly difficult because in the second quarter of 2016, we commenced international distribution of our first ever Abercrombie & Fitch men’s scent~~First Instinct~~ ~~and the Hollister fragrance duo,~~~~Wave~~~~. The 2017 third quarter included initial shipments of~~~~Icon Racing~~ ~~by Dunhill and~~~~Fantasia~~ ~~by Anna Sui, which are expected to energize sales by U.S. operations for the remainder of the year.~~

We maintain confidence in our future and we have strengthened advertising and promotional investments supporting most portfolio brands and accelerated brand development. We plan to continue to build upon the strength of our brands and our worldwide distribution network.

Net Sales to Customers by Region Nine months ended September 30,
(In millions) 2017 2016

North America $ 122.3 $ 106.4
Western Europe 121.8 115.5
Asia 70.5 61.9
Middle East 41.6 33.8
Central and South America 42.4 35.0
Eastern Europe 35.5 25.0
Other 7.6 8.7
$ 441.7 $ 386.3

~~Virtually all regions registered strong growth for the nine months ended September 30, 2017,~~ as compared to the corresponding period of the prior year. ~~Some~~Continuing the growth trend of the ~~strongest performing~~first quarter of 2023, second quarter sales by our U.S. operations grew substantially, up 42% largely from the continued success of GUESS fragrances which performed exceedingly well during the quarter across all geographies and was up 30% from the second quarter of 2022. This is driven by the sales of our newest pillars, Seductive Blue and Uomo Acqua. Second quarter GUESS brand sales more than made up for the first quarter logjam we experienced due to the ERP implementation. Of note, the significant growth in the quarter builds upon the 39% sales increase we reported for the second quarter of 2022. We also had strong sales of Ferragamo fragrances, which we have recently enriched with sister scents for the Signorina and Storie di Seta collections. Oscar de la Renta also performed strongly during the quarter. The increase was also driven by the addition and extension of Donna Karan and DKNY to our portfolio. They have climbed to become our second largest U.S. based brand in just one year under our expertise.

The first half of 2023 started on a strong note, and we look forward to executing our plans for the remainder of the year. Our brands are in high demand in a robust environment for the fragrance industry. We have a large number of brand extensions across many of our brands launching in the second half of the year, plus Abercrombie & Fitch Fierce joining our portfolio and the launches of Guess Bella Vita Paradiso, Karl Lagerfeld Les Parfums Matiéres and Van Cleef & Arpels Thé Amara, later in the year. In sum, 2023 has all the earmarks of another superb year as the growth catalysts currently far outweigh the headwinds, most notably somewhat limited travel retail business in Asia and supply chain disruptions which are slowly abating.

Net Sales to Customers by Region	Six months ended June 30,
(In millions)	2023		2022

North America	$	218.8	$	167.4
Western Europe		153.9		124.4
Asia		98.5		87.2
Middle East		51.0		44.9
Central and South America		46.9		38.7
Eastern Europe		45.6		28.4
Other		6.3		4.4
	$	621.0	$	495.4

In the first half of 2023 our largest market, North America, rose 31%, followed by Western Europe and Asia where comparable half year sales in both regions ~~were the laggards of recent years, namely~~increased 24% and 13%, respectively. Our sales in Eastern Europe, Central and South America and the Middle East ~~and Asia which increased 42%~~were also robust, up 60%, ~~23%~~21% and 14%, respectively. ~~Our largest markets, North America and Western Europe increased 15% and 6%, respectively.~~Additionally, our travel retail business is continuing to show signs of renewed life.

Gross margin Three months ended
September 30, Nine months ended
September 30,
(In millions) 2017 2016 2017 2016

Net sales $ 169.5 $ 157.6 $ 441.7 $ 386.3
Cost of sales 66.0 62.8 164.2 145.7

Gross margin $ 103.5 $ 94.8 $ 277.5 $ 240.6
Gross margin as a percent of net sales 61 % 60 % 63 % 62 %

Gross profit margin was 61% and 63% of net sales for the three and nine months ended September 30, 2017, as compared to 60% and 62% for the corresponding periods of the prior year. For European operations, gross profit margin was 65% and 66% for the three and nine months ended September 30, 2017, as compared to 64% and 66% for the corresponding periods of the prior year.

Page 23 19

INTER PARFUMS, INC. AND SUBSIDIARIES

Gross Profit margin	Three months ended						Six months ended
	June 30,						June 30,
(in millions)	2023			2022			2023			2022

European operations
Net sales	$	197.8		$	166.3		$	428.1		$	348.5
Cost of sales		73.1			55.1			147.4			115.6
Gross margin	$	124.7		$	111.2		$	280.7		$	232.9
Gross margin as a % of net sales		63.0	%		66.9	%		65.6	%		66.8	%

United States operations
Net sales	$	111.5		$	78.4		$	192.9		$	146.9
Cost of sales		47.7			35.8			82.2			67.4
Gross margin	$	63.8		$	42.6		$	110.7		$	79.5
Gross margin as a % of net sales		57.2	%		54.3	%		57.4	%		54.1	%

~~We carefully monitor movements in foreign currency exchange rates as almost 45% of our~~

For European based operations, ~~net sales are denominated in U.S. dollars, while most of our costs are incurred in euro. From a margin standpoint, a strong U.S. dollar has a positive effect on our~~ gross profit margin ~~while~~as a ~~weak U.S. dollar has a negative effect. The average dollar/euro exchange rate~~percentage of net sales was 63.0% and 65.6% for the three and ~~nine~~six months ended ~~September~~June 30, ~~2017 was 1.17 and 1.11,~~2023, respectively, as compared to ~~1.12~~66.9% and 66.8% for ~~both~~the corresponding periods of the prior ~~year giving rise~~year. A key driver in the decrease in gross profit margin for European based operations in 2023 is due to ~~a slight decrease~~an increase in inventory reserves in the first half of 2023 related to certain underperforming brands. As the Company experienced long lead time in obtaining and building inventory during COVID high levels of inventory investments were required to protect service levels. Excluding these one-time adjustments, gross margin as a percentage of sales for European based operations would be more favorable as compared to the ~~three months ended September 30, 2017. This decrease however, was mitigated~~prior period, driven by ~~increased gross margins from higher~~increases in pricing and product sales made directly to retailers through our own distribution subsidiaries. Increased sales of Rochas brand fragrances was a major contributor as its sales are concentrated in France and Spain, both of which are countries where we distribute directly to retailers.mix, partially offset by cost inflation.

For ~~U.S.~~United States operations, gross profit margin was ~~47%~~57.2% and ~~48%~~57.4% for the three and ~~nine~~six months ended ~~September~~June 30, ~~2017,~~2023, respectively, as compared to ~~47%~~54.3% and ~~49%~~54.1% for the corresponding periods of the prior year. The ~~decrease~~significant margin expansion stems from a number of factors. Firstly, for the ~~nine months ended September 30, 2017 is primarily~~most part, the ~~result~~price increases we took early 2023 weren’t fully offset yet by a higher cost of goods given our inventory coverage and FIFO accounting. Secondly, we are seeing favorable brand and channel mix, as a ~~decline~~higher portion of our higher priced fragrances are being sold directly to retailers as opposed to third-party distributors. Lastly, the significant increase in sales in the first half of ~~higher margin prestige products for Abercrombie & Fitch~~2023 allowed us to better absorb fixed expenses such as depreciation and ~~Hollister.~~point of sale expenses, as compared to the corresponding period of the prior year.

Generally, we do not bill customers for shipping and handling costs, and such costs, which aggregated ~~$1.8~~$3.6 million and ~~$4.3~~$7.5 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2017,~~2023, respectively, as compared to ~~$1.7~~$2.8 million and ~~$3.9~~$5.5 million for the corresponding periods of the prior year, are included in selling, general and administrative expenses in the consolidated statements of income. As such, our Company’s gross profit may not be comparable to the gross profit of other companies, which may include these expenses as a component of cost of goods sold.

Selling, general and administrative expenses Three months ended
September 30, Nine months ended
September 30,
(In millions) 2017 2016 2017 2016

Selling, general and administrative expenses $ 70.3 $ 62.5 $ 203.7 $ 179.3
Selling, general and administrative expenses as a percent of net sales 41 % 40 % 46 % 46 %

Page 20

INTER PARFUMS, INC. AND SUBSIDIARIES

Selling, general and administrative expenses	Three months ended						Six months ended,
	June 30,						June 30,
(In millions)	2023			2022			2023			2022

European Operations
Selling, general and administrative expenses	$	89.2		$	78.8		$	166.5		$	147.8
Selling, general and administrative expenses as a percent of net sales		45.1	%		47.4	%		38.9	%		42.4	%

United States Operations
Selling, general and administrative expenses	$	44.2		$	29.6		$	79.6		$	58.1
Selling, general and administrative expenses as a percent of net sales		39.7	%		37.8	%		41.3	%		39.5	%

Selling, general and administrative expenses increased 12% and 14% for the three and nine months ended September 30, 2017, respectively, as compared to the corresponding periods of the prior year. Selling, general and administrative expenses were 41% and 46% of net sales for the three and nine months ended September 30, 2017, as compared to 40% and 46% for the corresponding periods of the prior year. For European operations, selling, general and administrative expenses increased ~~16%~~13.2% and ~~18%~~12.6% for the three and ~~nine~~six months ended ~~September~~June 30, ~~2017,~~2023 as compared to the corresponding ~~periods~~period of the prior year, and represented ~~44%~~45.1% and 48% of sales for the three and nine months ended September 30, 2017, as compared to 41% and 48% for the corresponding periods of the prior year. For U.S. operations, selling, general and administrative expenses were 32% and 39% of sales for the three and nine months ended September 30, 2017, as compared to 34% and 40% for the corresponding periods of the prior year.

~~Promotion and advertising represented 15% and 18%~~38.9% of net sales for the three and ~~nine~~six months ended ~~September~~June 30, ~~2017,~~2023, respectively, as compared to ~~13%~~47.4% and ~~16%~~42.4% for the three and six months ended June 30, 2022, respectively. For United States operations, selling, general and administrative expenses increased 49.3% and 37.1% for the three and six months ended June 30, 2023, as compared to the corresponding period of the prior year, and represented 39.7% and 41.3% of net sales for the three and six months ended June 30, 2023, respectively, as compared to 37.8% and 39.5% for the three and six months ended June 30, 2022, respectively. As discussed in more detail below, the increased selling, general and administrative expenses as a percent of net sales are primarily the result of increases in promotion and advertising expenditures as well as the annualization impact of the structural investments in our US operations that we made throughout 2022 in order to support the new licenses of $7.0 million for the first half of 2023.

Promotion and advertising included in selling, general and administrative expenses aggregated $54.6 million and $89.8 million for the three and six months ended June 30, 2023, respectively, as compared to $45.9 million and $80.1 million for the corresponding periods of the prior year. Promotion and advertising ~~expenses aggregated $26.2 million~~represented 17.7% and ~~$79.6 million~~14.5% of net sales for the three and ~~nine~~six months ended ~~September~~June 30, ~~2017,~~2023, respectively, as compared to ~~$20.8 million~~18.8% and ~~$61.9 million~~16.2% for the corresponding periods of the prior year. ~~The increase in 2017 is the result~~Promotion and advertising are integral parts of ~~expenditures incurred within~~ our ~~European operations in connection with~~industry, and we continue to invest heavily to support new product launches ~~in 2017.~~and to build brand awareness. We ~~have significant~~believe that our promotion and advertising ~~programs underway for the final quarter~~efforts have had a beneficial effect on online net sales. All of ~~2017,~~our brands have benefited from newly launched and enhanced e-commerce sites in existing markets in collaboration with our retail customers on their e-commerce sites. We also continue to develop and implement omnichannel concepts and compelling content to deliver an integrated consumer experience. We anticipate that on a full year basis, promotion and advertising ~~expenditure~~expenditures will aggregate approximately 21% of ~~2017~~ net ~~sales.~~

~~Page 24~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~sales, which is in line with pre-COVID historical averages.

Royalty expense included in selling, general and administrative expenses aggregated ~~$11.2~~$24.0 million and ~~$29.2~~$48.1 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2017,~~2023, respectively, as compared to ~~$11.1~~$18.9 million and ~~$27.7~~$38.3 million for the corresponding periods of the prior year. Royalty expense represented ~~6.6%~~7.8% and 7.7% of net sales for the three and six months ended June 30, 2023, respectively, as compared to 7.7% of net sales for both the ~~three and nine months ended September 30, 2017, as compared to 7.0% and 7.2% of net sales for the~~ corresponding periods of the prior year. ~~The decline in royalty expense as a percentage of sales relates primarily to a lower minimum guaranteed royalty in the renewal of the S.T. Dupont license and the exit from the Balmain license.~~

Page 21

INTER PARFUMS, INC. AND SUBSIDIARIES

Service fees relating to the activities of our distribution subsidiaries aggregated $2.9 million and $8.2 million for the three and nine months ended September 30, 2017, respectively, as compared to $2.7 million and $7.2 million for the corresponding periods of the prior year. As a percentage of sales, service fees represented 1.7% and 1.9% for the three and nine months ended September 30, 2017, unchangedIncome from ~~that of the corresponding periods of the prior year.~~Operations

As a result of the above analysis regarding net sales, gross profit margins and selling, general and administrative expenses, income from operations increased 20% to $73.8 million for the nine months ended September 30, 2017, as compared to $61.3 million for the corresponding period of the prior year. For the three months ended September 30, 2017, income from operations increased 3% to $33.2 million, as compared to $32.3 million for the corresponding period of the prior year. Operatingour operating margins ~~were 20%~~aggregated 17.8% and ~~17% of net sales~~23.4% for the three and ~~nine~~six months ended ~~September~~June 30, ~~2017,~~2023, respectively, as compared to ~~20%~~18.6% and ~~16%~~21.5% for the corresponding periods of the prior year.

Other Income and Expense

~~Interest~~Traditionally, interest expense aggregated $0.5 million and $1.5 million for the three and nine months ended September 30, 2017, respectively, as compared to $0.5 million and $2.2 million for the corresponding periods of the prior year. Interest expense iswas primarily related to the financing of brand and licensing acquisitions. However, in April 2021, we completed the ~~Rochas brand~~ acquisition ~~and~~of the headquarters of Interparfums SA. The acquisition was financed by a 10-year €120 million (approximately $130.4 million) bank loan which bears interest at one-month Euribor plus 0.75%. Also in 2021, approximately €80 million of the variable rate debt was swapped for ~~the nine months ended September 30, 2016, includes~~variable rate debt with a ~~$0.2 million loss relating to the~~maximum interest rate of 2%. The swap ~~as compared~~effectively exchanges the variable interest rate to a $0.4 million gain in the 2017 period. We use the credit lines available to us, as needed, to finance our working capital needs as well as our financing needs for brand acquisitions. Long-term debt including current maturities aggregated $65.6 million and $84.7 million asfixed rate of ~~September 30, 2017 and 2016, respectively.~~approximately 1.1%.

Foreign currency loss aggregated $0.3 and $1.3 million for the three and nine months ended September 30, 2017, respectively, as compared to $0.3 million and $0.4 million for the corresponding periods of the prior year. We ~~typically~~ enter into foreign currency forward exchange contracts to manage exposure related to receivables from unaffiliated third parties denominated in a foreign currency and occasionally to manage risks related to future sales expected to be denominated in a foreign currency.

~~Page 25~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~ Gains and losses on foreign currency transactions have not been significant. Almost 50% of net sales of our European operations are denominated in U.S. dollars.

Interest ~~income aggregated $0.6 million~~ and ~~$2.8 million for the three and nine months ended September 30, 2017, respectively, as compared to $0.8 million and $2.7 million for the corresponding periods of the prior year. Cash~~investment (income) loss represents interest earned on cash and cash equivalents and short-term investments. As of June 30, 2023, short-term investments ~~are primarily invested~~include approximately $0.9 million of marketable equity securities of other companies in ~~certificates~~the luxury goods sector. In the first quarter of ~~deposit with varying maturities.~~2023, the Company sold marketable securities which generated a gain of $3.1 million. Interest and investment (income) loss for the three and six months ended June 30, 2023, includes approximately $3.4 million of losses on such marketable equity securities.

Income Taxes

~~Excluding the 2016 settlement, our~~Our consolidated effective ~~income~~ tax rate was ~~33%~~23.4% and 24.2% for ~~both~~ the ~~three and nine~~six months ended ~~September~~June 30, ~~2017,~~2023 and 2022, respectively.

The effective tax rate for European operations was 25% for each of the six months ended June 30, 2023 and June 30, 2022.

Our effective tax rate for U.S. operations was 17.4% for the six months ended June 30, 2023, as compared to ~~33% and 34%~~22% for the corresponding ~~periods~~period of the prior year. Our effective tax ~~rates differ~~rate differs from the 21% statutory ~~rates~~rate due to benefits received from the ~~effect~~exercise of stock options as well as deductions we are allowed for a portion of our foreign derived intangible income, slightly offset by state and local ~~taxes and tax rates in foreign jurisdictions. We~~taxes.

Other than as discussed above, we did not experience any significant changes in tax rates, ~~during the period,~~ and none were expected in jurisdictions where we operate.

~~Net income and earnings per share~~

(In thousands except per share data) Three Months Ended
September 30, Nine Months Ended
September 30,
2017 2016 2017 2016

Net income European operations $ 18,435 $ 18,629 $ 44,347 $ 33,852
Net income U.S. operations 3,668 2,850 5,134 4,804

Net income 22,103 21,479 49,481 38,656

Less: Net income attributable to the noncontrolling interest 5,026 5,240 12,287 9,252

Net income attributable to Inter Parfums, Inc. $ 17,077 $ 16,239 $ 37,194 $ 29,404

Earnings per share:

Net income attributable to Inter Parfums, Inc. common shareholders:
Basic $ 0.55 $ 0.52 $ 1.19 $ 0.95
Diluted $ 0.55 $ 0.52 $ 1.19 $ 0.94

Weighted average number of shares outstanding:
Basic 31,175 31,080 31,163 31,058
Diluted 31,307 31,171 31,281 31,138

Page 26 22

INTER PARFUMS, INC. AND SUBSIDIARIES

Net Income

	Three months ended June 30,				Six months ended June 30,
(In thousands)	2023		2022		2023		2022

Net income European operations	$	26,950	$	24,529	$	87,515	$	64,305
Net income United States operations		15,568		9,991		25,911		16,506

Net income		42,518		34,520		113,426		80,811

Less: Net income attributable to the noncontrolling interest		7,566		6,903		24,406		17,895

Net income attributable to Inter Parfums, Inc.	$	34,952	$	27,617	$	89,020	$	62,916

Net income ~~increased 3%~~attributable to ~~$22.1~~European operations was $27.0 million and $87.5 million for the three and six months ended ~~September~~June 30, ~~2017,~~2023, respectively, as compared to ~~$21.5~~$24.5 million and $64.3 million for the corresponding period of the prior year. Net income ~~increased 28%~~attributable to ~~$49.5~~United States operations was $15.6 million and $25.9 million for the ~~nine~~three and six months ended ~~September~~June 30, ~~2017,~~2023, respectively, as compared to ~~$38.7~~$10.0 million and $16.5 million for the corresponding period of the prior year. The ~~reasons for~~ significant fluctuations in net income for both European operations and United States operations are directly related to the previous discussions relating to changes in sales, gross margin, selling, general and administrative expenses and the settlement with the French Tax Authorities. As previously discussed, European based product sales increased 19% for the nine months ended September 30, 2017, as compared to the corresponding period of the prior year, while gross profit margins as a percentage of sales for European operations were relatively unchanged and selling, general and administrative expenses increased 18% for the period. In addition, for our European operations, net income for the nine months ended September 30, 2016, includes the effect of the $1.9 million income tax settlement with the French Tax Authorities.

With respect to our United States operations, for the nine months ended September 30, 2017, sales declined 2% while gross margin and selling, general and administrative expenses both declined 1% as a percentage of sales, as compared to the corresponding period of the prior year.expenses.

The noncontrolling interest arises from our ~~73%~~72% owned subsidiary in Paris, Interparfums SA, which is also a publicly traded company as ~~27%~~28% of Interparfums SA shares trade on the NYSE Euronext. ~~The noncontrolling interest is also affected by the profitability of Interparfums SA’s 51% owned distribution subsidiaries in Germany and Spain.~~ Net income attributable to the noncontrolling interest is directly related to the profitability of our European operations and aggregated ~~27% and~~ 28% of European ~~operations’~~operations net income for ~~the three and nine months ended September 30, 2017, respectively, as compared to 28% and 27% for the corresponding~~all periods ~~of the prior year.~~

~~Adjusted~~presented. Net ~~Income Attributable to Inter Parfums, Inc.~~

Adjusted Net Income Attributable to Inter Parfums, Inc., is deemed a “non-GAAP financial measure” under the rules of the Securities and Exchange Commission. This non-GAAP measure is calculated using GAAP amounts derived from our consolidated financial statements. Adjusted net incomemargins attributable to Inter Parfums, Inc. ~~has limitations~~for the six months ended June 30, 2023 and should not be considered in isolation or as a substitute for net income, operating income, cash flow from operations or other consolidated income or cash flow data prepared in accordance with GAAP. Because not all companies use identical calculations, this presentation of adjusted income may not be comparable to a similarly titled measure of other companies.2022 aggregated 14.3% and 12.7%, respectively.

~~Adjusted Net Income Attributable to Inter Parfums, Inc. Reconciliation~~

Adjusted net income attributable to Inter Parfums, Inc. is defined as net income attributable to Inter Parfums, Inc., plus the 2016 nonrecurring tax settlement, net of the portion of the settlement attributable to the noncontrolling interest. We believe that certain investors consider adjusted net income attributable to Inter Parfums, Inc. a useful means of evaluating our financial performance.

~~Page 27~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~

~~The following table provides a reconciliation of net income attributable to Inter Parfums, Inc. to adjusted net income attributable to Inter Parfums, Inc.~~

(in thousands except per share data) Nine Months Ended
September 30,
2017 2016

Net income attributable to Inter Parfums, Inc. $ 37,194 $ 29,404
Nonrecurring tax settlement (net of portion attributable to the noncontrolling interest of $500) — 1,400

Adjusted net income attributable to Inter Parfums, Inc. $ 37,194 $ 30,804

Adjusted net income attributable to Inter Parfums, Inc. common stockholders:
Basic $ 1.19 $ 0.99
Diluted $ 1.19 $ 0.99

Weighted average number of shares outstanding:
Basic 31,163 31,058
Diluted 31,281 31,138

Liquidity and Capital Resources

~~The Company’s~~Our conservative financial ~~position remains strong. At September~~tradition has enabled us to amass significant cash balances. As of June 30, ~~2017, working capital aggregated $377 million and~~2023, we had ~~a working capital ratio of 3.4 to 1. Cash and~~$187 million in cash, cash equivalents and short-term investments, ~~aggregated $231 million,~~ most of which is held in euro by our European operations and is readily convertible into U.S. dollars. We have not had any liquidity issues to date, and do not expect any liquidity issues relating to such cash and cash equivalents and short-term investments. As of June 30, 2023, short-term investments ~~held by our European operations.~~include approximately $2.2 million of marketable equity securities.

As of June 30, 2023, working capital aggregated $482 million and we had a working capital ratio of 2.4 to 1. Approximately ~~88%~~77% of the Company’s total assets are held by European operations, and approximately ~~$191~~$252 million of trademarks, licenses and other intangible assets are also held by European operations.

The Company is party to a number of licenses and other agreements for the use of trademarks and rights in connection with the manufacture and sale of its products expiring at various dates through 2039. In connection with certain of these license agreements, the Company is subject to minimum annual advertising commitments, minimum annual royalties and other commitments. See Item 8. Financial Statements and Supplementary Data – Note 12 – Commitments in our 2022 annual report on Form 10-K, which is incorporated by reference herein. Future advertising commitments are estimated based on planned future sales for the license terms that were in effect at December 31, 2022, without consideration for potential renewal periods and do not reflect the fact that our distributors share our advertising obligations.

Page 23

INTER PARFUMS, INC. AND SUBSIDIARIES

The Company hopes to continue to benefit from its strong financial position to potentially acquire one or more brands, either on a proprietary basis or as a licensee. ~~Opportunities~~In July 2023, we entered into a long-term global licensing agreement for ~~external growth continue~~the creation, development and distribution of fragrances and fragrance-related products under the Roberto Cavalli brand. This license took effect in July 2023, and we target to ~~be examined, with~~start shipping products as of November-December 2023. In December 2022, we entered into a long-term global licensing agreement for the ~~priority~~creation, development and distribution of ~~maintaining~~fragrances and fragrance-related products under the ~~quality and homogeneous nature of our portfolio. However, we cannot assure you that any~~Lacoste brand. This new license ~~or acquisition agreements will be consummated.~~takes effect January 2024.

Cash provided by operating activities aggregated $6.8 million for the six months ended June 30, 2023 compared to cash used in operating activities ~~aggregated $16.1 million and $12.6~~of $28.5 million for the ~~nine~~six months ended ~~September~~June 30, ~~2017 and 2016,~~2022, respectively. For the ~~nine~~six months ended ~~September~~June 30, ~~2017,~~2023, working capital items used ~~$70.9~~$115.4 million in cash from operating activities, as compared to ~~$57.0~~$117.2 million in the ~~2016~~2022 period. As usual, the most significant usage for both periods relates to the increase in accounts receivables as of September as compared to that of the prior December year end. This is expected and reflects the seasonality in our business whereby sales in the third quarter are significantly higher than those in the fourth quarter. Although ~~as set forth on the~~from a cash flow ~~statement,~~perspective accounts receivable ~~shows a 41% increase~~is up 18% from ~~2016~~ year end 2022, the ~~September 31, 2017 ending~~ balance is reasonable based on ~~third~~second quarter ~~2017~~2023 record sales levels and reflects ~~continued~~ strong collection activity as day’s sales outstanding ~~is relatively unchanged at 87~~was 68 days, ~~as compared to 85~~down from 76 days ~~for~~in the corresponding period of the prior year. ~~We continue to monitor collection activities actively and adjust customer credit limits~~From a cash flow perspective, inventory levels as ~~needed. Inventory levels are up approximately 28%~~of June 30, 2023, increased 23% from ~~2016~~ year end 2022 in support of our overall sales growth. Since 2021, we have strived to carry more inventory overall, source the same components from multiple suppliers and ~~reflect levels needed~~when possible, manufacture products closer to ~~support sales expectations and our new product launches.~~

~~Page 28~~

~~INTER PARFUMS, INC. AND SUBSIDIARIES~~where they are sold.

Cash flows ~~used in~~provided by investing activities in ~~2017~~2023 reflect ~~the purchase~~purchases and sales ~~in our European operations,~~ of short-term investments. These investments ~~are primarily~~include certificates of deposit with maturities greater than three months. Approximately ~~$62~~$34 million of such certificates of deposit contain penalties where we would forfeit a portion of the interest earned in the event of early withdrawal.

Our business is not capital intensive as we do not own any manufacturing facilities. ~~However, on~~On a full year basis, we typically spend approximately ~~$4.0~~$5.0 million on tools and molds, depending on our new product development calendar. Capital expenditures also include amounts for office fixtures, computer equipment and industrial equipment needed at our distribution centers. In December 2016, the Company agreed to a buyout of its Balmain license, effective December 31, 2016, for a payment aggregating €5.4 million (approximately $5.9 million). The Company received the buyout payment in May 2017.

In connection with the 2015 acquisition of the Rochas brand, we entered into a 5-year term loan payable in equal quarterly installments of €5.0 million ($5.9 million) plus interest. In order to reduce exposure to rising variable interest rates, the Company entered into a swap transaction effectively exchanging the variable interest rate to a fixed rate of approximately 1.2%. The swap is a derivative instrument and is therefore recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

Our short-term financing requirements are expected to be met by available cash on hand at ~~September~~June 30, ~~2017, cash generated by operations~~2023, and short-term credit lines provided by domestic and foreign banks. The principal credit facilities for ~~2017~~2023 consist of a ~~$20.0~~$25 million unsecured revolving line of credit provided by a domestic commercial bank and approximately ~~$30.0~~$8 million in credit lines provided by a consortium of international financial institutions. There ~~were~~was $5 million of short-term borrowings outstanding pursuant to these facilities as of June 30, 2023 and no short-term borrowings outstanding as of ~~both September~~June 30, ~~2017 and September 30, 2016.~~2022.

Page 24

INTER PARFUMS, INC. AND SUBSIDIARIES

In ~~October 2016, the~~February 2022, our Board ~~of Directors~~ authorized a ~~13%~~100% increase in the annual dividend to ~~$0.68~~$2.00 per ~~share and in October 2017,~~share. In February 2023, the Board ~~authorized a~~of Directors further ~~24% increase in~~increased the annual dividend to ~~$0.84~~$2.50 per share. The next quarterly cash dividend of ~~$0.21~~$0.625 per share is payable on ~~January 15, 2018~~September 30, 2023, to shareholders of record on December 29, 2017. Dividends paid also include dividends paid once per year to the noncontrolling shareholders of Interparfums SA, which aggregated $5.9 million and $4.9 million for the nine months ended September ~~30, 2017 and 2016, respectively. The annual cash dividends represent a small part of our cash position and are not expected to have any significant impact on our financial position.~~15, 2023.

We believe that funds provided by or used in operations can be supplemented by our present cash position and available credit facilities, so that they will provide us with sufficient resources to meet all present and reasonably foreseeable future operating needs.

Inflation rates in the U.S. and foreign countries in which we operate did not have a significant impact on operating results for the ~~nine~~six months ended ~~September~~June 30, ~~2017.~~2023.

Page 29 25

INTER PARFUMS, INC. AND SUBSIDIARIES

Item 3:

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

General

We address certain financial exposures through a controlled program of risk management that primarily consists of the use of derivative financial instruments. We primarily enter into foreign currency forward exchange contracts in order to reduce the effects of fluctuating foreign currency exchange rates. We do not engage in the trading of foreign currency forward exchange contracts or interest rate swaps.

Foreign Exchange Risk Management

We periodically enter into foreign currency forward exchange contracts to hedge exposure related to receivables denominated in a foreign currency and to manage risks related to future sales expected to be denominated in a currency other than our functional currency. We enter into these exchange contracts for periods consistent with our identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on the receivables and cash flows of Interparfums SA, ~~our French subsidiary,~~ whose functional currency is the euro. All foreign currency contracts are denominated in currencies of major industrial countries and are with large financial institutions, which are rated as strong investment grade.

All derivative instruments are required to be reflected as either assets or liabilities in the balance sheet measured at fair value. Generally, increases or decreases in fair value of derivative instruments will be recognized as gains or losses in earnings in the period of change. If the derivative is designated and qualifies as a cash flow hedge, then the changes in fair value of the derivative instrument will be recorded in other comprehensive income.

Before entering into a derivative transaction for hedging purposes, we determine that the change in the value of the derivative will effectively offset the change in the fair value of the hedged item from a movement in foreign currency rates. Then, we measure the effectiveness of each hedge throughout the hedged period. Any hedge ineffectiveness is recognized in the income statement.

At ~~September~~June 30, ~~2017,~~2023, we had foreign currency contracts in the form of forward exchange contracts ~~in the amount~~ of approximately U.S. ~~$22.6~~$38.0 million and GB ~~£11.5~~£2.0 million ~~which all have~~with maturities of less than one year. We believe that our risk of loss as the result of nonperformance by any of such financial institutions is remote.

Interest Rate Risk Management

We mitigate interest rate risk by monitoring interest rates, and then determining whether fixed interest rates should be swapped for floating rate debt, or if floating rate debt should be swapped for fixed rate debt. We entered into an interest rate swap in June 2015 on €100 million of debt, effectively exchanging the variable interest rate to a fixed rate of approximately 1.2%. This derivative instrument is recorded at fair value and changes in fair value are reflected in the accompanying consolidated statements of income.

Page 30 26

INTER PARFUMS, INC. AND SUBSIDIARIES

Item 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rule 13a-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q (the “Evaluation Date”). Based on their review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date, our ~~Company’s~~Company's disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the quarterly period covered by this report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, the ~~Company’s~~Company's internal control over financial reporting.

Part II. Other Information

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

Item (c).

Inter Parfums, Inc. Purchase of Common Stock¹
Period	Total Number of Shares Purchased	Average price paid per share	Total number of shares purchased as part of publicly announced plans or programs	Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs
April 1-30	0	n/a	43,060	123,000 shares
May 1-31	0	n/a	43,060	123,000 shares
June 1-30	42,000	$135.87	85,060	81,000 shares
Total	42,000	$135.87	85,060	81,000 shares

Items 1. Legal Proceedings, 1A. Risk Factors, 3. Defaults Upon Senior Securities, 4. Mine Safety Disclosures and 5. Other Information, are omitted as they are either not applicable or have been included in Part I.

~~Item 2:~~

~~UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS~~

~~On September 12, 2017, we granted an option to purchase 2,000~~¹ All shares ~~for a five year period at the exercise price of $40.15 per share, the fair~~were purchased in open market value of our common stock on the date of grant, to one nonemployee director who was elected to our board of directors for the first time, under our 2004 Nonemployee Director Stock Option Plan. Such option vests 25% each year over a four year period on a cumulative basis. This transaction was exempt from the registration requirements of Section 5 of the Securities Act under Sections 4(2) and 4(6) of the Securities Act. The option holder agreed that, if the option is exercised, the option holder would purchase her common stock for investment and not for resale to the public.transactions.

Page 31 27

INTER PARFUMS, INC. AND SUBSIDIARIES

~~Item 6.~~

~~EXHIBITS~~

Item 6. Exhibits.

The following documents are filed herewith:

Exhibit No.	Description	Page Number	Description	Page Number

31.1	Certifications required by Rule 13a-14(a) of Chief Executive Officer	33	Certifications required by Rule 13a-14(a) of Chief Executive Officer	29

31.2	Certifications required by Rule 13a-14(a) of Chief Financial Officer and Principal Accounting Officer	34	Certifications required by Rule 13a-14(a) of Chief Financial Officer and Principal Accounting Officer	30

32.1	Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Executive Officer	35	Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Executive Officer	31

32.2	Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Financial Officer and Principal Accounting Officer	36	Certification required by Section 906 of the Sarbanes-Oxley Act of Chief Financial Officer and Principal Accounting Officer	32

101	Interactive data files		Interactive data files

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on the 8th day of ~~November 2017.~~August 2023.

		INTER PARFUMS, INC.

	By:	/s/ ~~Russell Greenberg~~Michel Atwood
		~~Executive Vice President and~~ Chief Financial Officer

Page 32 28

	September 30, 2017			September 30, 2016

Weighted average expected stock-price volatility		29	%		33	%
Weighted average expected option life		5 years			5 years
Weighted average risk-free interest rate		1.9	%		1.4	%
Weighted average dividend yield		2.1	%		2.2	%

	Three months ended				Nine months ended
(In thousands)	September 30,				September 30,
	2017		2016		2017		2016
Numerator:
Net income attributable to Inter Parfums, Inc.	$	17,077	$	16,239	$	37,194	$	29,404
Denominator:
Weighted average shares		31,175		31,080		31,163		31,058
Effect of dilutive securities:
Stock options		132		91		118		80
Denominator for diluted earnings per share		31,307		31,171		31,281		31,138

Earnings per share:
Net income attributable to Inter Parfums, Inc. common shareholders:
Basic	$	0.55	$	0.52	$	1.19	$	0.95
Diluted		0.55		0.52		1.19		0.94

$ in millions				Increase (decrease)
	Change			to fair value

Weighted average cost of capital		+10	%	$	(16.2	)
Weighted average cost of capital		-10	%	$	20.0
Future sales levels		+10	%	$	17.0
Future sales levels		-10	%	$	(17.0	)

Net Sales to Customers by Region	Nine months ended September 30,
(In millions)	2017		2016

North America	$	122.3	$	106.4
Western Europe		121.8		115.5
Asia		70.5		61.9
Middle East		41.6		33.8
Central and South America		42.4		35.0
Eastern Europe		35.5		25.0
Other		7.6		8.7
	$	441.7	$	386.3